The relationship of glutamate and glutamine and metabolic profiling in focal epilepsy using 7T CRT-FID-MRSI
Author Block: S. Chambers, H. Shayeste, P. Lazen, L. Haider, E. Pataraia, G. Kasprian, W. Bogner, S. Trattnig, G. Hangel; Vienna/AT
Purpose: Identifying epileptogenic foci is essential in therapy-planning and predictive for post-operative seizure freedom in epilepsy. In this work we present a novel MRSI technique (CRT-FID) at 7T, allowing for ultra-high resolution whole-brain maps in focal epilepsy. We offer a qualitative analysis of its feasibility in identifying and characterizing metabolic alterations over multiple pathologies.
Methods or Background: Following informed written consent, forty-two patients with focal epilepsy (16-52 years, 21 females/21 males) underwent a 3D-MRSI protocol in 15min with a 3.4 mm isotropic resolution at 7T using a 32Rx/1Tx-coil. Data processing involved spectral quantification and ratio mapping of Glu, Gln, Ins, tCho, tCr and NAA normalized to NAA and tCr. Furthermore, the concentration estimates of Glu and Gln were qualitatively assessed in seizure onset zones.
Results or Findings: Though we could find no consistent metabolic pattern throughout pathologies, ratio maps showed high detectability of lesions, identifying alterations in seizure onset zones in 78,6% when normalized to NAA. This detection rate was reduced to 71,2% when normalized to creatine. Of the assessed ratios, Ins/tNAA and Cho/tNAA showed highest stability across patients, whereas Glu/tNAA and Gln/tNAA showed varying directionality of changes.
Assessing these changes further in relation to clinical parameters such as the seizure frequency, we found a trend for relative increases of Gln/Glu in patients with low seizure frequencies and the inverse for high seizure frequencies.
Conclusion: 7T CRT-FID-MRSI shows promising results in identifying metabolic alterations in patients suffering from focal epilepsy, even in the absence of structural lesions.
Furthermore, this orientational study may point to an altered glutamate/glutamine cycle in epilepsy, potentially the result of altered energy metabolism pathways in chronic epilepsy.
Limitations: This study is limited by the small cohort size and qualitative nature of the analysis.
Funding for this study: This research was funded by the FWF grant 10.55776/KLI1121, of the Mayor of the Federal Capital Vienna (Project Number 21186).
Has your study been approved by an ethics committee? Yes
Ethics committee - additional information: Ethic committee number: EK 1039/2020